These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3362274)

  • 21. Incidence of hyperkalaemia induced by indomethacin in a hospital population.
    Zimran A; Kramer M; Plaskin M; Hershko C
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):107-8. PubMed ID: 3926071
    [No Abstract]   [Full Text] [Related]  

  • 22. Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin.
    Gheno G; Cinetto L; Savarino C; Vellar S; Carraro M; Randon M
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):373-7. PubMed ID: 12851802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encephalopathy associated with sulindac.
    Neufeld MY; Korczyn AD
    Hum Toxicol; 1986 Jan; 5(1):55. PubMed ID: 2936673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of indomethacin and sulindac upon the blood pressures of individuals with untreated labile or mild hypertension.
    Lewis RV; McLay J; Maclean D; Tregaskis B
    J Hum Hypertens; 1989 Aug; 3(4):233-7. PubMed ID: 2677375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indomethacin-induced hyperkalemia in three patients with gouty arthritis.
    Findling JW; Beckstrom D; Rawsthorne L; Kozin F; Itskovitz H
    JAMA; 1980 Sep; 244(10):1127-8. PubMed ID: 7411769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulindac does not spare renal prostaglandins.
    Waslen TA; McCauley FA; Wilson TW
    Clin Invest Med; 1989 Apr; 12(2):77-81. PubMed ID: 2650941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs.
    Greenberg GN
    South Med J; 1988 Nov; 81(11):1463-4. PubMed ID: 3187641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indomethacin- and Moduretic--induced hyperkalemia.
    Mor R; Pitlik S; Rosenfeld JB
    Isr J Med Sci; 1983 Jun; 19(6):535-7. PubMed ID: 6862860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium interaction with sulindac and naproxen.
    Ragheb M; Powell AL
    J Clin Psychopharmacol; 1986 Jun; 6(3):150-4. PubMed ID: 3711365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prerenal azotemia: differentiation of hyperureagenesis from renal hypoperfusion using urinary urea nitrogen data.
    Sklar AH; Riesenberg LA; Ur Rehman A; Smith S; Rivera-Padilla H
    Int J Artif Organs; 1996 Mar; 19(3):164-9. PubMed ID: 8675360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indomethacin or sulindac at night in rheumatoid arthritis.
    Schorn D; Seymour MA
    S Afr Med J; 1981 Jun; 59(25):913-4. PubMed ID: 7015541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coumarin therapy during antirheumatism therapy with sulindac].
    Schenk H; Klein G; Haralambus I; Goebel R
    Z Rheumatol; 1980; 39(3-4):102-8. PubMed ID: 6968485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
    Weir MR; Bakris GL; Bushinsky DA; Mayo MR; Garza D; Stasiv Y; Wittes J; Christ-Schmidt H; Berman L; Pitt B;
    N Engl J Med; 2015 Jan; 372(3):211-21. PubMed ID: 25415805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.
    Muzzarelli S; Maeder MT; Toggweiler S; Rickli H; Nietlispach F; Julius B; Burkard T; Pfisterer ME; Brunner-La Rocca HP;
    Am J Cardiol; 2012 Mar; 109(5):693-8. PubMed ID: 22152974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune hemolytic anemia associated with sulindac.
    Johnson FP; Hamilton HE; Liesch MR
    Arch Intern Med; 1985 Aug; 145(8):1515-6. PubMed ID: 4026480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulindac and renal impairment.
    Whelton A; Bender W; Vaghaiwalla F; Hall-Craggs M; Solez K
    JAMA; 1983 Jun; 249(21):2892-3. PubMed ID: 6842802
    [No Abstract]   [Full Text] [Related]  

  • 37. Indomethacin-induced hyperkalemia and renal failure in multiple myeloma.
    Paladini G; Tonazzi C
    Acta Haematol; 1982; 68(3):256-60. PubMed ID: 6814155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulindac hepatotoxicity.
    Whittaker SJ; Amar JN; Wanless IR; Heathcote J
    Gut; 1982 Oct; 23(10):875-7. PubMed ID: 7117907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulindac-induced acute pancreatitis mimicking gallstone pancreatitis.
    Sugerman HJ
    Am Surg; 1989 Sep; 55(9):536-8. PubMed ID: 2774359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulindac-induced elevation of serum cyclosporine concentration.
    Sesin GP; O'Keefe E; Roberto P
    Clin Pharm; 1989 Jun; 8(6):445-6. PubMed ID: 2663332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.